# WEKA Data Platform Cyber Resilience for Pharmaceutical Industry

## Overview

WEKA (formerly WekaIO) provides a high-performance parallel file system designed for AI, HPC, and life sciences workloads. The WEKA Data Platform delivers enterprise-grade data protection features including snapshots, encryption, multi-tenancy, and disaster recovery — critical for pharmaceutical environments handling sensitive research and manufacturing data.

## WEKA Data Platform Architecture

### Parallel File System (WekaFS)
WekaFS is a distributed, parallel file system optimized for GPU-accelerated computing and HPC workloads. It delivers:
- Sub-millisecond latency for AI/ML training workloads
- Massive throughput for genomics and molecular simulation
- Multi-protocol support (POSIX, NFS, SMB, S3, GPUDirect Storage)
- Linear scalability across nodes

### Primary Markets
WEKA focuses on three primary verticals:
1. Financial Services Industry (FSI)
2. Life Sciences and Pharmaceutical
3. AI/ML and Deep Learning

## Data Protection Features

### Snapshots
- Instant local data snapshots managed per filesystem
- Snap-to-Object technology for off-site backup
- Snapshots can be sent to S3-compatible object tier on any schedule
- Policy-based snapshot management for automated protection
- Space-efficient snapshot technology minimizes storage overhead

### Encryption
- End-to-end encryption for data in-flight and at-rest
- Governance, risk, and compliance (GRC) support
- Key management integration
- FIPS-compliant encryption standards

### Multi-Tenancy
- Strict data isolation between research teams, departments, or tenants
- Per-filesystem quotas and access controls
- Authenticated mounts for secure access
- Network segmentation support

### Disaster Recovery
- Cloud bursting for overflow capacity during peak research workloads
- Archive and backup integration with S3 object stores
- Cross-site replication for disaster recovery
- Hybrid cloud management for on-premises and cloud deployments

## Life Sciences and Pharmaceutical Applications

### Genomics and Sequencing
- High-throughput storage for Next-Generation Sequencing (NGS) data
- Parallel processing of genomic pipelines (BWA, GATK, STAR)
- Protection of genomic datasets with immutable snapshots
- Scalable storage for growing biobank data

### Drug Discovery and Molecular Simulation
- GPU-accelerated molecular dynamics (GROMACS, AMBER, NAMD)
- AI/ML model training for drug candidate screening
- Virtual screening with high-throughput docking
- Structure-based drug design data management

### Clinical Research
- High-performance storage for medical imaging (DICOM, NIfTI)
- Real-world evidence (RWE) analytics
- Clinical data warehouse acceleration
- Biostatistics and analysis workloads

### Manufacturing Analytics
- Process Analytical Technology (PAT) data at scale
- Real-time quality monitoring data streams
- Predictive maintenance analytics for manufacturing equipment
- Digital twin simulations for process optimization

## Cybersecurity Considerations for Pharma

### Protecting High-Value Research Data
- Drug discovery data represents billions in R&D investment
- Genomic datasets are irreplaceable and expensive to regenerate
- AI models trained on proprietary data are high-value targets
- Clinical trial data is subject to strict regulatory protection

### WEKA Security Posture
- Authenticated mounts prevent unauthorized filesystem access
- Encryption protects data even if storage media is physically compromised
- Snapshot immutability prevents ransomware from encrypting recovery copies
- Multi-tenancy isolation prevents lateral movement between research projects

### Integration with Pharma Security Architecture
- Compatible with existing pharma network security infrastructure
- Supports integration with SIEM platforms for security monitoring
- Role-based access aligned with pharmaceutical organizational structures
- Audit logging for GxP compliance and regulatory inspections

## Pharma IT Components Protected by WEKA

### Research Computing
- HPC clusters for computational chemistry
- GPU farms for AI-driven drug discovery
- Genomics analysis pipelines
- Bioinformatics workflows

### Data Lakes
- Multi-modal research data repositories
- Clinical data analytics platforms
- Real-world evidence databases
- Pharmacovigilance data stores

## Competitive Positioning
WEKA differentiates through extreme performance for data-intensive workloads, making it particularly suited for pharmaceutical organizations running large-scale AI, genomics, and simulation workflows where both performance and data protection are critical.
